Back to News
Oct 9, 2025 12:00 PM

Optime Care Terminates Distributor Agreement for Korlym® (mifepristone)

ST. LOUIS, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Following 10+ years of service to Cushing's syndrome patients, Optime Care, a national specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, today announces termination of its agreement as the distributor for Korlym® (mifepristone).

Reinforcing its commitment to patient-centric care and drawing upon specialized experience and expertise to optimize each individual patient treatment journey, adherence to therapy and clinical outcomes, Optime Care prides itself on timely access and affordability of life-changing therapies.

Donovan Quill, founder, Optime Care, says, "We are proud of our team's support and dedication to Korlym® patients. We have been their exclusive distributor for over 10 years and it saddens me that we will no longer be servicing these patients that we have grown to know ...